Mark J Foley Revance Therapeutics, Inc. (RVNC) insider trading activity

Mark J Foley is President & CEO of Revance Therapeutics, Inc.. Currently has a direct ownership of 0 shares of RVNC, which is worth approximately $0. The most recent transaction as insider was on Oct 13, 2021, when has been sold 42,096 shares (Common Stock) at a price of $23.08 per share, resulting in proceeds of $971,576. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

100.0% 3M change

100.0% 12M change

Total Value Held $0

Mark J Foley Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Oct 13 2021	SELL Payment of exercise price or tax liability	$971,576 $23.08 p/Share	42,096 Reduced 5.19%	769,065 Common Stock
Jun 30 2021	BUY Other acquisition or disposition	$21,247 $24.09 p/Share	882 Added 0.11%	811,161 Common Stock
Feb 02 2021	BUY Grant, award, or other acquisition	-	40,715 Added 4.78%	810,279 Common Stock
Oct 13 2020	SELL Payment of exercise price or tax liability	$1,825,848 $27.62 p/Share	66,106 Reduced 7.91%	769,564 Common Stock
Sep 30 2020	SELL Payment of exercise price or tax liability	$3,601,783 $25.14 p/Share	143,269 Reduced 20.05%	571,231 Common Stock
Sep 30 2020	BUY Grant, award, or other acquisition	-	301,000 Added 29.64%	714,500 Common Stock
Jul 23 2020	BUY Grant, award, or other acquisition	-	264,439 Added 24.04%	835,670 Common Stock

Also insider at

GKOS

GLAUKOS Corp Healthcare

MJF

Mark J Foley

President & CEO

Nashville, TN

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RVNC shares.

Notify only if

Value

Insider Trading

Get notified when an Revance Therapeutics, Inc. insider buys or sells RVNC shares.

Notify only if

Operation

Value

Type

News

Receive news related to Revance Therapeutics, Inc.

Track Activities on RVNC

Account